Shiva Biogenetic Pharmaceuticals Private Limited

Shiva Biogenetic Pharmaceuticals Private Limited - pharma in Solan, Himachal Pradesh, India. FY 2026 financials & compliance.
CIN U24032HP2005PTC010765 Incorporated 16 September 2005 ROC Himachal Pradesh HQ Solan, Himachal Pradesh, India
Active Private Limited Company pharma MSME · Medium
Revenue · FY 2025
₹107.81 Cr
▼ 23% YoY
Net profit · FY 2025
₹1.39 Cr
Net margin 1.3%
EBITDA · FY 2025
₹3.9 Cr
EBITDA margin 3.6%
Authorised capital
₹3.32 Cr
Registered with MCA
Paid-up capital
₹2.25 Cr
Issued & subscribed
Open charges
₹21 Cr
Satisfied ₹18.46 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
149
Provident fund records

About Shiva Biogenetic Pharmaceuticals Private Limited

Data last updated:

Shiva Biogenetic Pharmaceuticals Private Limited is a private limited company based in Solan, Himachal Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 September 2005 and has been in existence for over 21 years.

The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24032HP2005PTC010765. Its GSTIN is 02AAJCS9364F1Z8 (Himachal Pradesh). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹3.32 Cr and a paid-up capital of ₹2.25 Cr. It is led by directors including Kapil Bhardwaj and Kanhaiya Bhardwaj.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Village Manpura Tehsil Baddi, Solan Himachal Pradesh, Himachal Pradesh, India – 174101.

As per the financials filed for FY 2025, the company reported a revenue of ₹107.81 Cr, a decline of 23% compared to the previous year. For the same year it recorded a net profit of ₹1.39 Cr (net margin 1.3%) and EBITDA of ₹3.9 Cr (EBITDA margin 3.6%). Revenue has declined at a compounded annual rate (CAGR) of 12% over three years and 5% over five years.

The company has about 149 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Shiva Biogenetic. As per MCA filings, the company has open charges of ₹21 Cr and satisfied charges of ₹18.46 Cr on record. Court records list 12 cases involving the company, including 4 filed by the company and 8 filed against it; 6 cases are pending. The company has 9 deals on record (6 secondary share transfers, 3 funding rounds), with disclosed funding of ₹2.24 Cr; the latest was in June 2023. Its 3 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 2 smaller; the largest is Chemtech Intermediates Limited with revenue of ₹109 Cr. The company has 4 MSME Form 1 returns on record between 2019 and 2022, listing 388 overdue payments to 98 micro and small suppliers.

Shiva Biogenetic Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0000845). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website shivabiogenetic.com.

Company details

CIN U24032HP2005PTC010765
Registration Number 010765
Incorporation Date 16 September 2005
ROC Himachal Pradesh
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-HP-11-0000845

CIN history

Shiva Biogenetic Pharmaceuticals has one previous CIN (Corporate Identification Number): U24032DL2005PTC140862. The current CIN is U24032HP2005PTC010765, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24032HP2005PTC010765Current
U24032DL2005PTC140862Previous

Recognitions & Rankings of Shiva Biogenetic Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Medium (2023-24)
Udyam number
UDYAM-HP-11-0000845

Contact details

Shiva Biogenetic Pharmaceuticals Private Limited's registered office is in Solan, Himachal Pradesh. Its website is shivabiogenetic.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Village Manpura Tehsil Baddi, Solan Himachal Pradesh, Himachal Pradesh, India – 174101
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Shiva Biogenetic Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Shiva Biogenetic Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Shiva Biogenetic Pharmaceuticals operates one associated brand: Shiva Biogenetic. Each brand links to its own profile.

BrandDescriptionWebsite
Pharmaceutical manufacturing and services in India, focusing on third-party operations and quality products.shivabiogenetic.com

Business activity

The main business activity of Shiva Biogenetic Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Shiva Biogenetic Pharmaceuticals Private Limited, buy the company report.

Financials of Shiva Biogenetic Pharmaceuticals Private Limited

FY 2024 filings available

Shiva Biogenetic Pharmaceuticals Private Limited reported revenue of ₹107.81 Cr (down 23% YoY) for FY 2025.

Revenue · FY 2025
₹107.81 Cr ▼ 23%
Net profit · FY 2025
₹1.39 Cr margin 1.3%
EBITDA · FY 2025
₹3.9 Cr margin 3.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 23%
3 years · compounded
▼ 12%
5 years · compounded
▼ 5%
EBITDA CAGR growth
1 year
▼ 20%
3 years · compounded
▼ 16%
5 years · compounded
▼ 7%

Revenue has declined at a compounded annual rate (CAGR) of 5% over five years, including a 23% fall in the latest year. EBITDA fell 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹3.9 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.39 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin3.6%
Net Profit Margin1.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Shiva Biogenetic Pharmaceuticals Private Limited, buy the company report.

Board of directors of Shiva Biogenetic Pharmaceuticals Private Limited

Shiva Biogenetic Pharmaceuticals has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Kapil BhardwajDirector27 Feb 201016 Years 8 MonthsCurrent
Kanhaiya BhardwajDirector31 Dec 20241 Years 10 MonthsCurrent
Shailendra Kumar SinghDirector02 Feb 200719 Years 9 MonthsCurrent
Parsan Kumar SinghDirector13 May 20224 Years 6 MonthsCurrent

Peer comparison

Shiva Biogenetic Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Chemtech Intermediates Limited₹109 Cr (FY 2025)33.0%Vadodara, Gujarat, India
Shiva Biogenetic Pharmaceuticals Private Limitedthis company₹107.81 Cr (FY 2025)₹1.39 Cr1.3%-23.0%149Solan, Himachal Pradesh, India
Shivalik Remedies Private Limited₹107.31 Cr (FY 2025)11.0%New Delhi, Delhi, India
Genetek Lifesciences Private Limited₹107.01 Cr (FY 2024)18.0%Nagpur, Maharashtra, India

To see the full peer comparison of Shiva Biogenetic Pharmaceuticals Private Limited, buy the company report.

Auditor

Shiva Biogenetic Pharmaceuticals Private Limited is audited by AARYAA & ASSOCIATES for the financial year 2024.

Auditor firmFinancial yearFirm registration number
AARYAA & ASSOCIATESFY 2024015935N

Shareholding

The shareholding of Shiva Biogenetic Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Shiva Biogenetic Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹21 Cr
Satisfied charges
₹18.46 Cr
Breakdown by lending institutions
State Bank of India₹21.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
26 Nov 2021100525812State Bank of India₹2 CrOpen
03 Jan 2018100162777State Bank of India₹19 CrOpen
23 Jun 201410510067Axis Bank Limited₹1.6 CrSatisfied
25 Mar 201010215226Others₹4 CrSatisfied
25 Mar 201010215028Axis Bank Limited₹2.25 CrSatisfied

To see the full charge records of Shiva Biogenetic Pharmaceuticals Private Limited, buy the company report.

Total charge records: 8 View all charges

Deals & funding

Shiva Biogenetic Pharmaceuticals Private Limited has 9 deals on record (6 secondary share transfers, 3 funding rounds), with disclosed funding of ₹2.24 Cr; the latest was in June 2023.

Total deals
9
Secondary share transfers
6
Funding rounds
3
Disclosed funding
₹2.24 Cr

Deals on record (5 of 9)

WhenDealAmountParties
Jun 2023Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
May 2023Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Sep 2020Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Mar 2014Secondary share transferUndisclosedBuyer: 4 individuals
Seller: 2 individuals
Jan 2012Funding round₹19.5 LakhInvestors: an individual

To see the full deal history of Shiva Biogenetic Pharmaceuticals Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Shiva Biogenetic Pharmaceuticals Private Limited has 4 MSME Form 1 returns on record between 2019 and 2022, listing 388 overdue payments to 98 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 98)

SupplierAmount dueDue sinceReported on
an individual supplier
Fortcaps Healthcare Limited
Keshav Hichem Private Limited
Sain Packaging Private Limited
Grand Tech Solution

To see the full MSME payment records of Shiva Biogenetic Pharmaceuticals Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Shiva Biogenetic Pharmaceuticals Private Limited has a workforce of 149 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
149
Active EPFO establishments
1
Employee growth
10.4%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27149
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Shiva Biogenetic Pharmaceuticals Private Limited, buy the company report.

GST

Shiva Biogenetic Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
02AAJCS9364F1Z8Himachal PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Shiva Biogenetic Pharmaceuticals Private Limited, buy the company report.

Recent activity

Shiva Biogenetic Pharmaceuticals Private Limited has 9 board changes on record since 2005: 5 appointments and 4 cessations. The latest: Kanhaiya Bhardwaj was appointed as Director on 31 Dec 2024.

Appointed
Kanhaiya Bhardwaj was appointed as Director.
Ceased
Sushila Devi ceased to be Director.
Charges
A charge with State Bank Of India of Rs. 19.00 Cr registered on 03 Jan 2018 with Charge ID 100162777 was modified on 26 Dec 2024.
AGM
Shiva Biogenetic Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Shiva Biogenetic Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Himachal Pradesh.
Charges
A charge registered on 16 Jan 2009 via Charge ID 10139854 with Director Of Industries Himachal Pradesh was fully satisfied on 19 Jul 2023.
Appointed
Parsan Kumar Singh was appointed as Director.
Charges
A charge with State Bank Of India amounted to Rs. 2.00 Cr with Charge ID 100525812 was registered on 26 Nov 2021.
Ceased
Parsan Kumar Singh ceased to be Managing Director.
Charges
A charge registered on 23 Jun 2014 via Charge ID 10510067 with Axis Bank Limited was fully satisfied on 18 Jan 2019.
Charges
A charge registered on 25 Mar 2010 via Charge ID 10215028 with Axis Bank Limited was fully satisfied on 18 Jan 2019.
Charges
A charge registered on 25 Mar 2010 via Charge ID 10215226 with Others was fully satisfied on 31 Mar 2018.

17 earlier events are in the company report.

Frequently asked questions

Shiva Biogenetic Pharmaceuticals is an active private limited company based in Solan, Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 September 2005 (21+ years old) and is registered under CIN U24032HP2005PTC010765.

Shiva Biogenetic Pharmaceuticals has 4 current directors:

The latest financial statements of Shiva Biogenetic Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Shiva Biogenetic Pharmaceuticals is 02AAJCS9364F1Z8, registered in Himachal Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Shiva Biogenetic Pharmaceuticals is U24032HP2005PTC010765. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Shiva Biogenetic Pharmaceuticals has 12 court cases on record: 4 filed by the company and 8 filed against it. 6 are pending. Most are in the district courts.

Shiva Biogenetic Pharmaceuticals was incorporated on 16 September 2005, making it 21+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.

Shiva Biogenetic Pharmaceuticals has 9 deals on record (6 secondary share transfers, 3 funding rounds), with disclosed funding of ₹2.24 Cr; the latest was in June 2023.

The peers of Shiva Biogenetic Pharmaceuticals by revenue are Chemtech Intermediates Limited, Shivalik Remedies Private Limited, Genetek Lifesciences Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Kanhaiya Bhardwaj was appointed as Director on 31 Dec 2024. Sushila Devi ceased to be Director on 31 Dec 2024. Parsan Kumar Singh was appointed as Director on 13 May 2022. Shiva Biogenetic Pharmaceuticals has 9 board changes on record in total.

Yes, Shiva Biogenetic Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-HP-11-0000845).

Shiva Biogenetic Pharmaceuticals has 4 MSME Form 1 returns on record between 2019 and 2022, listing 388 overdue payments to 98 micro and small suppliers. The latest return was filed on 07 May 2022.